- Home
- NNBR vs EPRX Comparison
NNBR vs EPRX Comparison
Compare NNBR & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNBR
- EPRX
- Stock Information
- Founded
- NNBR 1980
- EPRX 2011
- Country
- NNBR United States
- EPRX Canada
- Employees
- NNBR N/A
- EPRX N/A
- Industry
- NNBR Industrial Machinery/Components
- EPRX
- Sector
- NNBR Industrials
- EPRX
- Exchange
- NNBR Nasdaq
- EPRX NYSE
- Market Cap
- NNBR 132.4M
- EPRX 109.7M
- IPO Year
- NNBR 1994
- EPRX N/A
- Fundamental
- Price
- NNBR $2.77
- EPRX $3.17
- Analyst Decision
- NNBR
- EPRX Strong Buy
- Analyst Count
- NNBR 0
- EPRX 1
- Target Price
- NNBR N/A
- EPRX $9.00
- AVG Volume (30 Days)
- NNBR 1.5M
- EPRX 6.3K
- Earning Date
- NNBR 03-10-2025
- EPRX 02-07-2025
- Dividend Yield
- NNBR N/A
- EPRX N/A
- EPS Growth
- NNBR N/A
- EPRX N/A
- EPS
- NNBR N/A
- EPRX N/A
- Revenue
- NNBR $470,310,000.00
- EPRX N/A
- Revenue This Year
- NNBR N/A
- EPRX N/A
- Revenue Next Year
- NNBR $0.69
- EPRX N/A
- P/E Ratio
- NNBR N/A
- EPRX N/A
- Revenue Growth
- NNBR N/A
- EPRX N/A
- 52 Week Low
- NNBR $2.38
- EPRX $2.20
- 52 Week High
- NNBR $5.40
- EPRX $4.08
- Technical
- Relative Strength Index (RSI)
- NNBR 40.50
- EPRX N/A
- Support Level
- NNBR $2.56
- EPRX N/A
- Resistance Level
- NNBR $4.67
- EPRX N/A
- Average True Range (ATR)
- NNBR 0.36
- EPRX 0.00
- MACD
- NNBR -0.01
- EPRX 0.00
- Stochastic Oscillator
- NNBR 20.09
- EPRX 0.00
About NNBR NN Inc.
NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets. It also operates in China, Mexico, Brazil, Germany, and other countries.
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.